🇺🇸 FDA
Pipeline program

Aliskiren

Novartis-ST-01

Approved small_molecule completed

Quick answer

Aliskiren for IgA Nephropathy is a Approved program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
IgA Nephropathy
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials